Cite
Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases
MLA
Roberto Troisi, et al. Radiologic and Pathologic Response to Neoadjuvant Chemotherapy Predicts Survival in Patients Undergoing the Liver-First Approach for Synchronous Colorectal Liver Metastases. Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4a8d471e34f6c622c1f8d58a5094b26&authtype=sso&custid=ns315887.
APA
Roberto Troisi, Oswald Varin, Giammauro Berardi, Peter Smeets, Federico Tomassini, Marc De Man, Anne Hoorens, Karen Geboes, Riccardo Ariotti, Stéphanie Laurent, & Jo Van Dorpe. (2018). Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
Chicago
Roberto Troisi, Oswald Varin, Giammauro Berardi, Peter Smeets, Federico Tomassini, Marc De Man, Anne Hoorens, et al. 2018. “Radiologic and Pathologic Response to Neoadjuvant Chemotherapy Predicts Survival in Patients Undergoing the Liver-First Approach for Synchronous Colorectal Liver Metastases,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e4a8d471e34f6c622c1f8d58a5094b26&authtype=sso&custid=ns315887.